Clinical Trials Directory

Trials / Completed

CompletedNCT00526994

Randomized Controlled Trial of Routine Screening for IPV

Randomized Controlled Trial of Routine Screening for Intimate Partner Violence

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
2,700 (actual)
Sponsor
Centers for Disease Control and Prevention · Federal
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a randomized controlled trial with three arms to establish the impact of screening and referral to services for women disclosing exposure to IPV.

Detailed description

Approximately 2675 women\* will be enrolled and randomized to one of 3 arms. In the first arm, participants will be screened, and if disclosing IPV, will receive information on available resources in the community. In arms two and three, participants will not be screened, but one group will receive information on available resources in the community and the other will not. All three groups will be assessed for quality of life (SF-12;standardized and validated scale with 12 questions that measure overall health (1 item), physical functioning (2 items), role limitations due to physical health problems (4 items), bodily pain (1 item), energy/fatigue (1 item), social functioning (1 item), psychological distress (1 item), and well being (1 item) in the past 4 weeks; items are summed to form a physical health composite scale and a mental health composite scale; each scale is standardized to have a mean of 50 and a standard deviation of 10 for the U.S. population with a possible range from 0 to 100; higher scores represent a better health state); disability; and utilization of health care and IPV services at baseline and at a 12 month follow-up. A pilot study, also using a randomized controlled trial design, will establish the feasibility, acceptability, and impact on disclosure rates, use of referral resources, and potential harms of three screening and referral strategies. \*sample size calculation based n needed to detect a standardized effect size of 0.3 with an α=.05 (1-tailed)and ß=.20 if there's a 20% IPV (+) rate and 30% lost-to-follow-up rate.

Conditions

Interventions

TypeNameDescription
OTHERscreenedAsked 4 questions on current exposure to intimate partner violence; if positive, receives referral information
BEHAVIORALuniversal educationreceives referral information

Timeline

Start date
2008-05-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2007-09-10
Last updated
2013-07-31
Results posted
2013-07-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00526994. Inclusion in this directory is not an endorsement.